PolyPid Unveils PD01B Candidate; D-PLEX100 PDUFA Date Remains Nov. 28, 2026

PolyPid said PD01B, a Kynatrix-based candidate for diabetic foot infections, is expected to enter pre-IND and first-in-human studies in H2 2027. D-PLEX100 remains under FDA Priority Review.